RecallDepth
Class II Ongoing

Carbidopa, Levodopa, Entacapone Tablets, 25 mg/100 mg/200 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ, 08816, Manufactured by Suven Pharmaceuticals Limited, Pashamylaram, Telangana, 205307, India. NDC# 16571-691-01

This recall is currently active, issued October 22, 2025. It was issued by Rising Pharma Holding, Inc..

Company
Rising Pharma Holding, Inc.
Recall Initiated
October 7, 2025
Posted
October 22, 2025
Recall Number
D-0029-2026
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
2,064 100-count bottles
Firm Location
East Brunswick, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

Product mix up: complaint received that sealed medication bottle contained Carbidopa, Levodopa, and Entacapone film-coated tablets (37.5 mg/150 mg/200 mg) instead of labelled lower strength Carbidopa, Levodopa, and Entacapone film-coated tablets (25 mg/100 mg/200 mg).

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # CS25070, exp. date 03/31/2027

More recalls by Rising Pharma Holding, Inc.

View all recalls by this company →

Other recent Class II Drug recalls